Enrofloxacin/OVA
Product Specifications
Background
It is a bactericidal agent. The bactericidal activity of enrofloxacin is concentration-dependent, with susceptible bacteria cell death occurring within 20–30 minutes of exposure. Enrofloxacin has demonstrated a significant post-antibiotic effect for both Gram-negative and Gram-positive bacteria and is active in both stationary and growth phases of bacterial replication. Enrofloxacin is partially deethylated by CYP450 into the active metabolite ciprofloxacin, which is also a fluoroquinolone antibiotic, used preferentially in humans.
Expression System
Native protein
Conjugation
Unconjugated
Tag
No tag
Source
Small molecule-conjugated carrier protein
Applications
Others
Endotoxin
Not Tested
Purity
>95% by SDS-PAGE
Buffer
0.01M PBS (pH7.4)
Storage Conditions
Store at -70°C or -20°C. Avoid repeated freeze/thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2919402-01 20 µg
Recombinant CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase (pgsA)
Sign In for Pricing
View Details orb2919402-02 100 µg
Recombinant CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase (pgsA)
Sign In for Pricing
View Details 
A04643-2-Cy3 100 µg/Vial
Anti-Rab4/RAB4A Antibody Picoband®, Cy3 Conjugate
Sign In for Pricing
View Details